What's in Arcturus Therapeutics, Inc.'s pipeline?

Arcturus Therapeutics, Inc. has 14 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 3 in Phase 2, 8 in Phase 1.

Which companies overlap with Arcturus Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Pfizer Inc., CanSino Biologics Inc., National Institute of Allergy and Infectious Diseases (NIAID), Pfizer, Tan Tock Seng Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/arcturus-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Arcturus Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arcturus Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 3 Phase 2 8 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Influenza vaccine, adjuvanted	Influenza vaccine, adjuvanted	phase 3	Vaccine		Immunology
ARCT-2303	ARCT-2303	phase 3	Self-amplifying RNA (saRNA) vaccine	Tumor-associated antigens (KRAS, WT1, PRAME)	Oncology
Placebo booster	Placebo booster	phase 3

Therapeutic area mix

Oncology · 2
Immunology · 1
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer Inc. · 2 shared drug classes
CanSino Biologics Inc. · 2 shared drug classes
National Institute of Allergy and Infectious Diseases (NIAID) · 2 shared drug classes
Pfizer · 2 shared drug classes
Tan Tock Seng Hospital · 2 shared drug classes
University Health Network, Toronto · 2 shared drug classes
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
BioNTech SE · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Arcturus Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Arcturus Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/arcturus-therapeutics-inc. Accessed 2026-05-17.